FAQWhat is the best therapy for localized vitiligo?


An investigation from Egypt cites early systemic immunomodulation for recent localized vitiligo as a “successful approach” for achieving early control of disease activity. It helps to achieve early control of disease activity as well as minimize the incidence of recurrence. Early management of such cases is crucial; it is a race against time:

  • Disease activity is arrested following 3.65 ± 2.19 months of treatment.
  • Patients achieve complete repigmentation in a mean span of 6.88 ± 0.2 months.
  • Recurrence is seen in 32% of patients at the end of the 4-year follow up.
  • Despite recurrence, a localized disease was secured.